Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Percutaneous chemosaturation with melphalan for unresectable colorectal liver metastases
NL-OMON41379Phase 2Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in colorectal cancer (CRC), sponsored by Leiden University Medical Center. Planned start Sep 2013; status: not yet recruiting.
02
Drugs
melphalan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NL-OMON41379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41379.